CJC-1295 No DAC (Mod GRF 1-29)

CJC-1295 No DAC, also known as Modified GRF(1-29) or Mod GRF 1-29, is a synthetic analogue of the growth hormone-releasing hormone (GHRH). This compound is designed to stimulate the secretion of growth hormone (GH) from the anterior pituitary gland, thereby enhancing the natural pulsatile release of GH in the body. Its structural modifications allow for increased stability and a prolonged half-life compared to the native GHRH, making it a valuable tool for research into growth hormone dynamics.

Research has indicated that CJC-1295 No DAC may play a significant role in various studies focused on growth hormone regulation, metabolic processes, and potential therapeutic applications in conditions related to GH deficiency. By amplifying the pulsatile release of GH, this compound can aid in understanding the physiological and biochemical pathways influenced by growth hormone, as well as its effects on muscle growth, fat metabolism, and overall body composition.

Due to its specific mechanism of action, CJC-1295 No DAC is utilized in preclinical research to explore its efficacy and safety profile, as well as its potential applications in clinical settings. Researchers are particularly interested in its role in age-related decline in GH levels and its implications for muscle wasting and obesity.

For research and laboratory use only. Not for human consumption.